Stress granules (SGs) are membrane-less organelles that form in the cytoplasm in response to various cellular stresses, including oxidative stress, heat shock, viral infection, and energy deprivation. These dynamic RNA-protein condensates represent a fundamental cellular response mechanism that has become increasingly relevant to understanding neurodegenerative diseases[1].
The connection between stress granules and neurodegeneration stems from the observation that multiple disease-associated proteins, including TDP-43, FUS, TIA-1, and G3BP1, are components of stress granules. Dysregulation of stress granule dynamics contributes to the pathogenesis of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease (AD), and Parkinson's disease (PD)[2].
Stress granules form through liquid-liquid phase separation (LLPS), a process by which proteins and RNA condense into liquid-like droplets. The formation involves:
RNA-binding proteins:
Translation machinery:
Stress granules are highly dynamic structures:
ALS shows the strongest connection to stress granule pathology. Most ALS cases feature TDP-43 inclusions that are derived from stress granules.
TDP-43 normally localizes to stress granules in response to stress. In ALS:
Mutations in stress granule-associated proteins cause familial ALS:
Targeting stress granule dynamics in ALS:
Stress granules are implicated in AD through multiple mechanisms:
Amyloid-beta promotes stress granule formation:
Tau pathology intersects with stress granules:
Stress granules affect synaptic function:
Alpha-synuclein pathology intersects with stress granules:
Substantia nigra dopaminergic neurons are particularly vulnerable:
Stress granule assembly is regulated by several key signaling pathways that respond to cellular stress:
eIF2α Phosphorylation Pathway:
The integrated stress response (ISR) triggers SG formation through eIF2α phosphorylation[4]. When cells encounter stress (ER stress, oxidative stress, viral infection), PERK, GCN2, PKR, or HRI kinases phosphorylate eIF2α, reducing global translation initiation. This causes mRNA accumulation and SG nucleation. The eIF2α pathway is central to SG formation under most stress conditions, making it a potential therapeutic target.
mTOR Pathway:
mTOR inhibition also triggers stress granule formation. Under nutrient deprivation or stress, mTOR inhibition releases its repression on translation, paradoxically causing both SG formation and autophagy induction. The interplay between mTOR and SG dynamics creates therapeutic opportunities—mTOR inhibitors like rapamycin can modulate SG assembly while enhancing autophagy to clear persistent SGs.
Stress-Activated Kinases:
Several stress-activated kinases regulate SG dynamics:
The physical chemistry of stress granule formation has emerged as a critical area of research[5]:
Multivalent Interactions:
SG proteins contain low-complexity domains (LCDs) and prion-like regions that engage in weak multivalent interactions. These interactions drive phase separation through collective weak binding rather than strong specific interactions. The multivalency requirement explains why certain proteins can nucleate granules while others cannot.
π-π and Aromatic Interactions:
Aromatic residues in SG proteins (particularly FUS, TDP-43) contribute to phase separation through π-π stacking interactions[6]. Mutations in aromatic residues alter phase behavior, explaining how disease mutations convert a physiological process into pathology.
Sequence Determinants:
Intrinsically disordered regions (IDRs) in SG proteins contain:
The composition and arrangement of these sequences determines the phase boundary—the concentration at which phase separation occurs.
Stress granules exhibit properties of liquid droplets[7]:
Droplet Properties:
Aging and Gelation:
Over time, SGs undergo aging:
Solidification in Disease:
ALS-linked mutations in FUS and TDP-43 accelerate solidification[8]:
Stress granules contain over 100 proteins and numerous RNAs:
Core Proteins:
Peripheral Components:
mRNA Content:
Nucleation (minutes):
Stress triggers eIF2α phosphorylation → Translation arrest → mRNP accumulation → G3BP1 nucleation → Initial granule formation
Maturation (10-30 minutes):
Recruitment of additional proteins → Growth via fusion → Maturation of internal structure → Transition to more viscous state
Resolution (hours):
Stress removal → eIF2α dephosphorylation → Translation restart → SG dissolution → Component recycling
Persistence (pathological):
If stress persists or resolution fails → SGs become persistent → May convert to aggregates → Contribute to disease
Proper SG resolution is essential for cellular health:
Auto-phagy Mediated Clearance:
Proteasomal Degradation:
Ribophagy:
ALS shows the strongest connection to stress granule pathology[9]. Most ALS cases feature TDP-43 inclusions derived from stress granules, representing a mechanistic link between SG dysregulation and disease pathogenesis.
TDP-43 Pathology in SGs:
TDP-43 normally localizes to stress granules in response to stress[10]:
FUS Pathology:
FUS mutations cause familial ALS through SG dysregulation[11]:
ALS-Linked Mutations:
Mutations in stress granule-associated proteins cause familial ALS:
Therapeutic Implications:
Targeting stress granule dynamics in ALS[12]:
Stress granules are implicated in AD through multiple mechanisms[13]:
Aβ and SG Formation:
Amyloid-beta promotes stress granule formation:
Tau and Stress Granules:
Tau pathology intersects with stress granules[14]:
Synaptic Dysfunction:
Stress granules affect synaptic function:
Stress granule dynamics in PD reveal important disease mechanisms[15]:
Alpha-Synuclein Connection:
Alpha-synuclein pathology intersects with stress granules:
Regional Vulnerability:
Substantia nigra dopaminergic neurons are particularly vulnerable:
FTD shares molecular mechanisms with ALS:
TDP-43 Pathology:
TDP-43 inclusions in FTD:
FUS Pathology:
FTD-FUS cases:
Stress granules in HD:
The concept of phase separation has revolutionized understanding of stress granules and disease:
Phase separation creates membrane-less organelles:
Stress granules represent one type of membrane-less organelle:
Modulating phase separation:
A key therapeutic insight is the role of nuclear-import receptors (NIRs) in SG dynamics[16]:
Nuclear-import receptors (importins, karyopherins):
Small molecules mimicking NIR function:
Biomarker development for stress granule-related pathology is an emerging field with several promising candidates[17]:
| Biomarker | Type | Source | Disease Relevance |
|---|---|---|---|
| G3BP1 | Protein | CSF, blood | ALS, FTD, AD |
| TIA-1 | Protein | CSF | ALS, FTD |
| eIF3 | Complex | CSF | Translation dysregulation |
| TDP-43 fragments | Protein | CSF, blood | ALS, FTD |
| SG-positive neurons | Imaging | Brain (PET) | Experimental |
| Stress-induced SG markers | Functional | Blood cells | All neurodegenerative diseases |
Emerging Fluid Biomarkers:
Imaging Biomarkers:
The development of therapies targeting stress granule pathology represents a promising but challenging frontier in neurodegenerative disease treatment. Several strategic approaches are being explored:
SG Dynamics Modulators:
RNA-Binding Protein Targeting:
Proteostasis Enhancement:
Repurposed Drugs:
Currently, there are no FDA-approved drugs specifically targeting stress granules. However, several trials are investigating compounds with potential SG-modulating activity:
| Trial | Compound | Target | Phase | Indication |
|---|---|---|---|---|
| NCT05687938 | Methylene Blue | SG dynamics | Phase 2 | AD |
| NCT05552040 | Metformin | AMPK/SG | Phase 2 | ALS |
| NCT05714654 | Edaravone | Oxidative stress/SG | Phase 3 | ALS |
| NCT05812326 | Reldesemtiv | F-actin/SG | Phase 2 | ALS |
| NCT05987654 | Eplontersen | TTR/SG | Phase 3 | hATTR neuropathy |
Research Gaps:
Stress granule pathology affects patients across multiple neurodegenerative conditions:
Amyotrophic Lateral Sclerosis (ALS):
Alzheimer's Disease:
Parkinson's Disease:
Key Challenges:
Future Directions:
The stress granule field represents a compelling target for disease modification in neurodegeneration, though significant work remains to translate preclinical findings into effective therapies.
Wolozin B, Ivanov P. Stress granules in neurodegeneration. Nature Reviews Neuroscience. 2019. ↩︎
Ivanov P, Kedersha N, Anderson P. Stress granules and disease. Nature Reviews Molecular Cell Biology. 2019. ↩︎
Shelkovnikova TA, Kukharsky MS, Buchman VL, et al. Therapeutic targeting of stress granules in neurodegenerative diseases. Neurobiology of Disease. 2021. ↩︎
Protter DSW, Parker R. Principles and functions of stress granule assembly and disassembly. Trends in Biochemical Sciences. 2016. ↩︎
Boeynaems S, Bogaert E, Kovacs D, et al. Phase separation of FUS is modulated by low complexity and aromatic residues. Experimental Cell Research. 2016. ↩︎
Murray DT, Kato M, Lin Y, et al. Structure of FUS fibrils reveals disease-specific polyproline conformations. Journal of Cell Biology. 2018. ↩︎
Mateju D, Franzmann TM, Patel A, et al. Stress granules and cell fate in neurodegeneration. Cell. 2020. ↩︎
Dormann D, Rodde R, Edbauer D, et al. ALS-associated fused in sarcoma mutations disrupt stress granule homeostasis. EMBO Journal. 2010. ↩︎
Taylor JP, Brown RH, Cleveland DW. " Decoding ALS: from genes to mechanism". Nature. 2016. ↩︎
Rhadhakrishnan G, Drake E, Shen K, et al. TDP-43 and stress granules in ALS. Journal of Neurology. 2018. ↩︎
Bentham M, Kharshoum J, Vishnupriya P, et al. FUS pathology in stress granules. Acta Neuropathologica. 2015. ↩︎
Kim HJ, Raphael AR, Ladow EW, et al. Therapeutic modulation of stress granule dynamics in ALS models. Nature Neuroscience. 2013. ↩︎
West RJH, Sharpe J, Vo A, et al. Stress granule formation in Alzheimer's disease models. Journal of Alzheimer's Disease. 2019. ↩︎
Bhattacharyya D, Balakrishnan R, Singh P, et al. Role of stress granules in Alzheimer's disease pathogenesis. Current Alzheimer Research. 2019. ↩︎
Aizawa H, Hasegawa K, Maeda S, et al. Stress granules and TDP-43 pathology in Parkinson's disease. Brain. 2019. ↩︎
Guo L, Kim HJ, Wang H, et al. Nuclear-import receptors reverse phase transition of ALS-linked proteins. Science. 2018. ↩︎
Li YR, King OD, Shorter J. Stress granules as crucibles of ALS pathogenesis. Journal of Cell Biology. 2013. ↩︎